Obstetrics/Gynecology Women's Health
Women have a variety of health challenges that males do not. Furthermore, some health conditions that afflict both men and women can have differing effects on women.
Pregnancy, menopause, and disorders of the female organs are all unique difficulties. Women can have a safe pregnancy if they get prenatal care early and on a regular basis. They should also have the recommended screenings for breast cancer, cervical cancer, and bone density.
Many of the same health issues affect both men and women. However, these issues can have a distinct impact on women. Consider the following:
Women are more likely than males to die from a heart attack.
Women are more prone than men to display indicators of despair and anxiety.
In women, the consequences of sexually transmitted illnesses might be more severe.
Women are more likely than men to get osteoarthritis.
Dermatologists have significant training, spending 12 years or more in school to learn how to diagnose and treat over 3,000 skin, hair, and nail illnesses, as well as cosmetic concerns. Dermatologists are consulted for problems that go beyond the skin.
Information about Clinical Trials
Onyx Clinical’s Women’s Health teams are experts in the scientific approach, standard of care, growing regulatory requirements, and operational factors required to bring medications and devices to market that treat or prevent Women’s Health issues. Our significant experience in dermatology studies, together with our proven track record of success in the Women’s Health CRO market, means that we can adapt to each cardiovascular trial’s specific demands.
In order to ensure success, we help our clients:
- Plan and conduct dermatology studies for drug/device and Women’s Health safety in an efficient and effective manner.
- Conduct big Women’s Health endpoint trials efficiently while adhering to stringent safety guidelines.
- Integrate Women’s Health trials without difficulty.
Crucial Women's Health Information
Deep and Broad Women’s Health Experience
We’ve done hundreds of Phase I-IV Women’s Health trials for pharmaceuticals and medical devices since our establishment in 2017.
We have learned the following from these studies:
- Involved patients in nearly 50 different countries
- Contributed to countless Women’s Health NDAs
- Pioneered many of the preventative Women’s Health drugs and devices introduced in the past 15 years
- Conducted studies including acute care setting, drug/device combination, large outcome, thorough QT, as well as managing Clinical Endpoint Committees (CEC) and adjudication processes for numerous studies
